Starpharma Holdings Limited

符号: SPHRF

PNK

0.0774

USD

今天的市场价格

-3.8414
市盈率
-0.0396
PEG比率
31.89M
MRK市值
0.00%
DIV收益率

Starpharma Holdings Limited (SPHRF) 财务报表

Q: 什么是 Starpharma Holdings Limited (SPHRF) 总资产是多少？

Starpharma Holdings Limited (SPHRF) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Starpharma Holdings Limited (SPHRF). 的默认数据。公司收入显示 1.612 M 的平均值，即 67.285 % 增长率。整个期间的平均毛利润为 1.365 M，即 67.252 %. 平均毛利率为 0.772 %. 公司去年的净收入增长率为 -0.032 %，等于 -1.532 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Starpharma Holdings Limited 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 -0.213. 在流动资产领域，SPHRF 的报告货币为47.122. 这些资产中的很大一部分，即 35.18 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.295%. 公司的长期投资虽然不是其重点，但以报告货币计算的0（如果有的话）为0。这表明与上一报告期相比，0.000% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 2.75. 这一数字表明，0.010% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 34.815. 这方面的年同比变化率为 -0.281%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为8.235，存货估值为 2.77，商誉估值为 0（如有. 无形资产总额（如果有）按 0 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
balance-sheet.row.cash-and-short-term-investments	149.36	35.2	49.9	60.5	30.1	41.3	51.3	61.2	46	30.8	24	33.8	42.8	18.9	22.9	11.6	7.5	10.1	14.3	8.2	15.7	7.9	17.4	25.4	28.1	0	0
balance-sheet.row.short-term-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	14.74	8.2	7.8	8.4	6.1	6.1	6.1	4.2	4.1	4	4.4	5.3	1.9	0.9	1.3	1.5	1.8	1.3	2.8	0	0.5	0.4	0.3	0.3	0.7	0	0
balance-sheet.row.inventory	11.01	2.8	2.8	1.7	0.5	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0
balance-sheet.row.other-current-assets	14.82	0.9	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0	0.1	0	0	0
balance-sheet.row.total-current-assets	186.83	47.1	60.7	70.8	36.7	47.8	57.5	65.7	50.3	35.1	28.6	39.3	44.9	19.9	24.2	13.2	9.3	11.4	17.1	8.4	16.2	8.5	17.8	25.8	28.9	0	0
balance-sheet.row.property-plant-equipment-net	19.29	5	5.5	2.5	2.4	1.1	1.1	0.9	0.7	0.9	0.5	0.4	0.4	0.3	0.2	0.4	0.8	1.1	1.4	1.2	1.6	2	0.9	0.2	0.1	0	0
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	2	1.9	1.6	1.6	1.5	1.4	1.7	1.8	1.5	1.8	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0	0	0	0	0	0	0	6.1	6.5	6.2	7.2	7.5	8.2	11.4	13.4	13.1	16	4.1	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0	0	0	0	0	0	0	8.1	8.4	7.8	8.8	9	9.6	13.1	15.2	14.6	17.8	4.1	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	2.4	2.9	0.7	0.3	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	-4.96	-5	-5.5	-2.5	-2.4	-1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0
balance-sheet.row.total-non-current-assets	19.29	5	5.5	2.5	2.4	1.1	1.1	0.9	8.8	9.3	8.3	9.2	9.4	9.9	13.3	15.7	15.4	19	7.9	4.1	2.2	2.3	1	0.2	0.1	0	0
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	206.13	52.1	66.2	73.2	39.1	48.9	58.5	66.6	59	44.4	36.9	48.5	54.3	29.8	37.6	28.8	24.7	30.4	25	12.5	18.5	10.7	18.9	26	29.1	0	0
balance-sheet.row.account-payables	23.35	6.6	6.8	6.7	4.4	4.1	3	4	8.2	5.5	2.6	1.2	4.2	0.9	1.3	1.8	1.6	1.9	1.9	1.6	0.4	0.7	1.2	1	0.2	0	0
balance-sheet.row.short-term-debt	6.24	5.5	0.7	0.7	0.6	0	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	14.96	2.8	7.5	0.5	1	0	0	0	0	0	0	0.1	0.1	0	0	0.2	0.3	0.3	0.3	0.1	0.1	0.2	0	0	0	0	0
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.2	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	8.75	2.3	2.3	2.6	1.3	1.9	1.7	1.5	1.3	1.2	1.2	1.1	0.8	0.7	0.5	0.3	0.4	0.4	0.3	0.3	0.2	0.2	0.2	0.1	0	0	0
balance-sheet.row.total-non-current-liabilities	15.2	2.8	7.6	0.5	1.1	0	0.1	0.1	0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.6	1.4	0.7	0.2	0.1	0.2	0	0	0	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	13.17	2.8	4.2	1.2	1.6	0	0	0.1	0	0	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.3	0.5	0.1	0.2	0.3	0	0	0	0	0
balance-sheet.row.total-liab	54.02	17.3	17.8	10.9	7.8	6.5	5.2	5.6	9.6	6.8	3.9	2.6	5.6	2.1	2.7	3.3	4.3	4.7	3.7	2.5	0.9	1.5	1.6	1.1	0.2	0	0
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	962.81	240.7	240.7	240.6	193.7	193.6	193.6	193.5	193.5	160.9	140.3	140.1	139.2	105.4	101.8	85.6	78.7	76.2	65.4	46.8	46.8	33	33	33	33.1	0	0
balance-sheet.row.retained-earnings	-923.22	-234.2	-218.6	-202.4	-182.7	-168	-153.7	-143.5	-153.9	-131.2	-112.3	-97.6	-92.4	-78.7	-69.8	-63.4	-59.3	-51.8	-44.6	-36.8	-29.2	-23.7	-16	-8.1	-4.2	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	112.52	28.3	26.3	24.1	20.3	16.8	13.4	10.9	9.8	7.9	4.9	3.5	1.9	1	2.9	3.3	1	1.3	0.5	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-stockholders-equity	152.11	34.8	48.4	62.3	31.3	42.4	53.3	61	49.4	37.6	33	46	48.7	27.7	34.8	25.5	20.4	25.7	21.3	10	17.6	9.2	17	24.9	28.9	0	0
balance-sheet.row.total-liabilities-and-stockholders-equity	206.13	52.1	66.2	73.2	39.1	48.9	58.5	66.6	59	44.4	36.9	48.5	54.3	29.8	37.6	28.8	24.7	30.4	25	12.5	18.5	10.7	18.9	26	29.1	0	0
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0
balance-sheet.row.total-equity	152.11	34.8	48.4	62.3	31.3	42.4	53.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	206.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	2.4	2.9	0.7	0.3	0	0	0	0	0
balance-sheet.row.total-debt	21.2	8.3	8.2	1.2	1.6	0	0	0.1	0	0	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.3	0.5	0.1	0.2	0.3	0	0	0	0	0
balance-sheet.row.net-debt	-128.16	-26.9	-41.7	-59.3	-28.5	-41.2	-51.3	-61.1	-46	-30.8	-24	-33.7	-42.7	-18.9	-22.7	-11.3	-7.1	-9.7	-13.8	-8	-15.5	-7.6	-17.4	-25.4	-28.1	0	0

现金流量表

在 Starpharma Holdings Limited 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.011 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.019 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-610000.000. 与上一年相比， -0.270 发生了变化. 在同一时期，公司记录了 1.19, 0 和 -0.69，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -0.69，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
cash-flows.row.net-income	-12.59	-15.6	-16.2	-19.7	-14.7	-14.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.depreciation-and-amortization	1.72	1.2	1.1	0.9	0.9	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.deferred-income-tax	-2.01	-5.7	-4.6	-6.3	-5.9	-3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	2.06	2.1	2.2	3.7	3.6	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-0.49	-1	-0.1	-0.6	-0.3	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.account-receivables	-1.26	-1.3	0.6	-2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	0.05	0.1	-1.1	-1.2	-0.1	-0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.account-payables	0	-0.1	0.3	2.9	-0.4	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0.71	0.2	0	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-non-cash-items	2.85	5.6	4.4	7.1	5.6	2.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-cash-provided-by-operating-activities	-9.53	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-0.25	-0.6	-0.8	-0.2	-0.1	-0.3	-0.4	-0.6	-0.1	-0.7	-0.3	-0.2	-0.1	-0.1	0	0	0	-0.2	-0.5	-0.4	-0.2	-1.6	-0.9	-0.2
cash-flows.row.acquisitions-net	0	0	0	0	0	0	0	33.3	0	0	0	0	0	0	0	0	0	-0.1	0	-0.3	0	-0.9	0	0
cash-flows.row.purchases-of-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1.5	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0.01	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0
cash-flows.row.other-investing-activites	0.01	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	-0.23	-0.6	-0.8	-0.2	-0.1	-0.3	-0.4	32.7	0	-0.7	-0.3	-0.2	-0.1	-0.1	0	0	0	-0.3	-0.4	-1.6	-0.2	-2.5	-0.9	-0.2
cash-flows.row.debt-repayment	-4.78	-0.7	-4	-0.6	-0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	0	0	0	48.9	0	0	0	0	33.9	21.4	0.2	0.9	35.2	3.6	15.7	7.2	3.8	0	15	0	14.5	0	0.2	22.9
cash-flows.row.common-stock-repurchased	0	0	0	-1.9	0	0	0	0	-1.3	-0.9	0	0	-1.4	0	-0.6	-0.2	-0.3	0	-0.8	0	-0.7	0	0	-1.6
cash-flows.row.dividends-paid	0	0	0	-0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	-5.5	-0.7	7.2	0.6	-0.6	0	0	0	0	0	0	-0.1	-0.1	-0.1	-0.2	-0.2	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0	-0.4
cash-flows.row.net-cash-used-provided-by-financing-activities	-8.25	-0.7	3.2	46.3	-0.6	0	0	0	32.6	20.5	0.2	0.8	33.7	3.5	15	6.8	3.4	-0.1	14	-0.1	13.7	-0.1	0.2	20.8
cash-flows.row.effect-of-forex-changes-on-cash	0.1	0.1	0.2	-0.8	0.3	0.6	0.7	-0.5	0.3	0.6	0	0.2	0.1	-0.8	-0.1	1.4	-0.6	-0.4	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-61.9	-14.7	-10.6	30.4	-11.2	-10.1	-9.9	15.2	15.1	6.8	-9.8	-9	23.9	-3.9	11.3	4.1	-2.6	-4.2	6.1	-7.5	7.8	-9.5	-8	18.2
cash-flows.row.cash-at-end-of-period	61.36	35.2	49.9	60.5	30.1	41.3	51.3	61.2	46	30.8	24	33.8	42.8	18.9	22.9	11.6	7.5	10.1	14.3	8.2	15.7	7.9	17.4	25.4
cash-flows.row.cash-at-beginning-of-period	123.26	49.9	60.5	30.1	41.3	51.3	61.2	46	30.8	24	33.8	42.8	18.9	22.9	11.6	7.5	10.1	14.3	8.2	15.7	7.9	17.4	25.4	7.2
cash-flows.row.operating-cash-flow	-9.53	-13.5	-13.2	-14.8	-10.8	-10.3	-10.2	-17	-17.8	-13.6	-9.8	-9.8	-9.8	-6.5	-3.6	-4	-5.4	-3.4	-7.5	-5.8	-5.8	0	-7.3	-2.5
cash-flows.row.capital-expenditure	-0.25	-0.6	-0.8	-0.2	-0.1	-0.3	-0.4	-0.6	-0.1	-0.7	-0.3	-0.2	-0.1	-0.1	0	0	0	-0.2	-0.5	-0.4	-0.2	-1.6	-0.9	-0.2
cash-flows.row.free-cash-flow	-9.78	-14.2	-14	-15.1	-10.9	-10.7	-10.6	-17.6	-17.9	-14.3	-10.1	-10	-9.9	-6.6	-3.7	-4.1	-5.4	-3.6	-8	-6.2	-6	-1.6	-8.2	-2.6

利润表行

Starpharma Holdings Limited 的收入与上期相比变化了 -0.372%。据报告, SPHRF 的毛利润为 1.22。该公司的营业费用为 25.9，与上年相比变化了 31.999%. 折旧和摊销费用为 1.19，与上一会计期间相比变化了 0.107%. 营业费用报告为 25.9，显示31.999% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.393%. 营业收入为 -24.67，与上年相比变化了0.393%. 净利润的变化率为 -0.032%。去年的净收入为-15.64.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
income-statement-row.row.total-revenue	14.36	2.9	4.7	1.8	6	1.7	3.8	3	3.8	0.8	0.3	0	0.9	1.1	1.4	2	1.4	0.9	0	2	1.4	1.5	0.4	0	0	0	0
income-statement-row.row.cost-of-revenue	7.48	1.7	2.8	0.8	0.9	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit	6.88	1.2	1.9	1	5.1	1.4	3.8	3	3.8	0.8	0.3	0	0.9	1.1	1.4	2	1.4	0.9	0	2	1.4	1.5	0.4	0	0	0	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	25.98	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	3.83	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	6.37	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0	0.1	0.3	1.3	0.6	0	0.1	0	0.1	0	0	0.8	0.2	1.2	3.8	7.7	8.2	8.1	6.4	1.4	0.7	0	0.2	0.5	0	0	0
income-statement-row.row.operating-expenses	27.5	25.9	19.6	23.4	21.8	17	15.6	19.8	28.2	21.9	17	8.7	17.7	13.7	14	16.1	18	17.3	13.9	10.4	7.3	8.8	9.3	5.6	0	0	0
income-statement-row.row.cost-and-expenses	34.98	27.6	22.4	24.2	22.7	17.3	15.6	19.8	28.2	21.9	17	8.7	17.7	13.7	14	16.1	18	17.3	13.9	10.4	7.3	8.8	9.3	5.6	0	0	0
income-statement-row.row.interest-income	1.58	1.3	0.2	0.4	0.5	1.1	1.1	0.7	0.7	0.9	1	1.6	1.8	1	0.7	0.1	0.3	0.6	0.6	0.6	0.6	0.6	0.9	1.1	0	0	0
income-statement-row.row.interest-expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	6.37	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	1.62	1.4	0.3	1.3	0.6	0	0.1	0	0.1	0	0	0.8	0.2	1.2	3.8	7.7	8.1	7.9	5.8	0.8	0.4	-0.2	0.2	0.5	1.8	1.2	1.3
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0	0.1	0.3	1.3	0.6	0	0.1	0	0.1	0	0	0.8	0.2	1.2	3.8	7.7	8.2	8.1	6.4	1.4	0.7	0	0.2	0.5	0	0	0
income-statement-row.row.total-operating-expenses	1.62	1.4	0.3	1.3	0.6	0	0.1	0	0.1	0	0	0.8	0.2	1.2	3.8	7.7	8.1	7.9	5.8	0.8	0.4	-0.2	0.2	0.5	1.8	1.2	1.3
income-statement-row.row.interest-expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.depreciation-and-amortization	1.32	1.2	1.1	0.9	0.9	0.3	0.3	0.9	0.9	1.2	1.1	1.1	1.1	1.5	1.7	2	2.1	2	1	0.7	0.6	0.6	0.2	0.1	0	0	0
income-statement-row.row.ebitda-caps	-19.31	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-20.63	-24.7	-17.7	-22.4	-16.7	-15.6	-11.7	-15.2	-22.7	-18.9	-14.6	-5.2	-13.7	-8.9	-6.4	-4.3	-10.2	-10	-7.5	-7.6	-5.5	-7.5	-9.3	-5.6	-3.5	-2.3	-2.5
income-statement-row.row.income-before-tax	-19.01	-23.3	-16.2	-19.7	-14.7	-14.3	-10.3	-15.2	-22.7	-18.9	-14.6	-5.2	-13.7	-8.9	-6.4	-4.3	-8.2	-8	-7.5	-7.6	-5.5	-7.5	-8	-3.9	-1.8	-1.2	-1.3
income-statement-row.row.income-tax-expense	-6.42	-7.6	-1.3	-1.3	-1.4	-1.4	-1.4	-23.4	0.1	0	0	0.9	0.2	1.2	0	-0.2	-0.7	-0.7	5.8	-7.6	-5.5	-7.5	-8	-3.9	-1.8	-1.2	-1.3
income-statement-row.row.net-income	-12.59	-15.6	-16.2	-19.7	-14.7	-14.3	-10.3	8.2	-22.7	-18.9	-14.6	-5.2	-13.7	-8.9	-6.4	-4.1	-7.5	-7.2	-7.5	-7.6	-5.5	-0.2	0.1	-3.9	-1.8	-1.2	-1.3